IDEXX Laboratories, Inc. Revenue 2008–2025
IDEXX Laboratories, Inc. annual/quarterly revenue history and growth rate from 2008 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- IDEXX Laboratories, Inc. revenue for the quarter ending March 31, 2026 was 1.1 B, a 14.26% increase year-over-year.
- IDEXX Laboratories, Inc. revenue for the twelve months ending March 31, 2026 was 4.4 B, a 12.83% increase year-over-year.
- IDEXX Laboratories, Inc. annual revenue for 2025 was 4.3 B, a 10.42% increase from 2024.
- IDEXX Laboratories, Inc. annual revenue for 2024 was 3.9 B, a 6.46% increase from 2023.
- IDEXX Laboratories, Inc. annual revenue for 2023 was 3.7 B, a 8.72% increase from 2022.
- IDEXX Laboratories, Inc. annual revenue for 2022 was 3.4 B.
IDEXX Laboratories, Inc. (IDXX) — Frequently Asked Questions
IDEXX Laboratories, Inc. (IDXX) is a publicly traded US company. It has a market capitalization of $45.52B. In fiscal 2025 it reported revenue of $4.30B and net income of $1.06B. Explore IDXX's stock price, financial statements, earnings history, margins and key ratios below.
What is IDEXX Laboratories, Inc.'s market cap?
IDEXX Laboratories, Inc. (IDXX) has a market capitalization of $45.52B.
What is the IDXX stock price?
IDXX trades at $561.78 (+0.87% on the day).
How much revenue does IDEXX Laboratories, Inc. make?
IDEXX Laboratories, Inc. reported revenue of $4.30B in fiscal 2025.
Is IDXX profitable?
In fiscal 2025, IDEXX Laboratories, Inc. reported net income of $1.06B.
What is IDXX's P/E ratio?
Based on diluted EPS, IDXX has a price-to-earnings (P/E) ratio of about 42.9.